Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 — ExpreS2ion Biotech Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: ExpreS2ion And University Of Bologna Announce Research Collaboration

Feb 23 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION AND UNIVERSITY OF BOLOGNA ANNOUNCE RESEARCH
COLLABORATION TO TEST HER2-CVLP IN STATE-OF-THE-ART BREAST
CANCER MICE MODELS
    * RESEARCH COLLABORATION IS BUDGETED AND PLANNED FOR WITHIN
PROCEEDS FROM RECENT RIGHTS ISSUE.
    * COLLABORATION FOLLOWS RECENTLY PRESENTED IN-LICENSING OF
HER2-CVLP TECHNOLOGY FROM ADAPTVAC.
    * OUTCOME OF COLLABORATION IS EXPECTED TO SUPPORT
EXPRES2ION'S
BREAST CANCER VACCINE PROJECT AND WILL CONSTITUTE A PROOF OF
PRECLINICAL CONCEPT
    * RESEARCH COLLABORATION IS BUDGETED AND PLANNED FOR WITHIN
PROCEEDS FROM RECENT RIGHTS ISSUE

Source text for Eikon:  ID:nWkrblGV5D 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ExpreS2ion Biotech Holding AB

See all news